A landmark trial has shown that a gene therapy, known as AMT-130, may slow the progression of Huntington's disease. The treatment has been described as groundbreaking and promising, although some outlets are urging caution. The outcome of the trial is being seen as a significant breakthrough in the treatment of the disease.